Cancer Medicine
| 短名 | Cancer Med |
| Journal Impact | 2.93 |
| 国际分区 | ONCOLOGY(Q2) |
| 期刊索引 | SCI Q2中科院 2 区 |
| ISSN | 2045-7634 |
| h-index | 84 |
| 国内分区 | 医学(2区)医学肿瘤学(3区) |
CANCER MEDICINE 是一份经过同行评审的开放获取的跨学科期刊，可快速发表来自癌症科学领域的全球生物医学研究人员的研究成果。该杂志将考虑所有肿瘤学专业的投稿，包括但不限于以下领域：临床癌症研究转化研究 ∙ 临床试验 ∙ 化疗 ∙ 放射治疗 ∙ 手术治疗 ∙ 临床观察 ∙ 临床指南 ∙ 遗传咨询 ∙ 伦理考虑癌症生物学：分子生物学 ∙ 细胞生物学 ∙ 分子遗传学 ∙ 基因组学 ∙ 免疫学 ∙ 表观遗传学 ∙ 代谢研究 ∙ 蛋白质组学 ∙ 细胞病理学 ∙ 致癌作用 ∙ 药物发现和递送。癌症预防：行为科学 ∙ 心理社会研究 ∙ 筛查 ∙ 营养学 ∙ 流行病学和预防 ∙ 社区外展。 : 基因表达概况 ∙ 基因调控网络 ∙ 基因组生物信息学 ∙ 通路分析 ∙ 预后生物标志物。癌症医学发表原创研究文章、系统评论、荟萃分析和研究方法论文，以及特邀社论和评论。原始研究论文必须报告进行良好的研究，其结论得到论文中提供的数据的支持。
期刊主页投稿网址| 涉及主题 | 医学生物内科学遗传学癌症病理肿瘤科化学外科生物化学癌症研究数学统计基因免疫学计算机科学 |
| 出版信息 | 出版商: John Wiley and Sons Inc，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2012，原创研究文献占比: 92.91%，自引率:3.40%， Gold OA占比: 73.59% |
| 平均审稿周期 | 网友分享经验：19 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
2024-9-1
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
2024-9-1
Impact of thoracic radiotherapy on first‐line treatment outcomes in <scp>ES</scp>‐<scp>SCLC</scp> patients
2024-9-1
Human <scp>TCR</scp> repertoire in cancer
2024-9-1
Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
2024-9-1
<scp>TIM</scp>‐4 increases the proportion of <scp>CD4</scp><sup>+</sup><scp>CD25</scp><sup>+</sup><scp>FOXP3</scp><sup>+</sup> regulatory T cells in the pancreatic ductal adenocarcinoma microenvironment by inhibiting <scp>IL</scp>‐6 secretion
2024-9-1
Gut microbial subtypes and clinicopathological value for colorectal cancer
2024-9-1
Mental health in people living with and beyond colorectal cancer: A patient‐oriented constructivist grounded theory
2024-9-1
<scp>LncRNA CCAT2</scp> promotes the proliferation and metastasis of colorectal cancer through activation of the <scp>ERK</scp> and Wnt signaling pathways by regulating <scp>GNB2</scp> expression
2024-9-1
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
2024-9-1
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
2024-9-1
New clinical insights into the treatment of benign uretero‐ileal anastomotic stricture following radical cystectomy and urinary diversion
2024-9-1
Global disparities in cancer supportive care: An international survey
2024-9-1
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer
2024-9-1
Correction to “<scp>KBTBD7</scp> promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of <scp>PTEN</scp>”
2024-9-1
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (<scp>CAR</scp>) T‐cell therapy can be identified before cell administration
2024-9-1
Impact of positive <scp>CD4</scp> cells on event‐free survival in follicular lymphoma patients
2024-9-1
Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of <scp>MYCN</scp>
2024-9-1
Nomograms for predicting recurrence of <scp>HER2</scp>‐positive breast cancer with different <scp>HR</scp> status based on ultrasound and clinicopathological characteristics
2024-9-1
Effectiveness of mobile health for exercise promotion on cardiorespiratory fitness after a cancer diagnosis: A systematic review and meta‐analysis
2024-9-1
Global, regional, and national burdens of leukemia from 1990 to 2019: A systematic analysis of the global burden of disease in 2019 based on the <scp>APC</scp> model
2024-9-1
Which social determinants of health have the highest impact in community oncology to advance patient care equity and improve health outcomes? A scoping review
2024-9-1
Gender and melanoma subtype‐based prognostic implications of <i>MUC16</i> and <i>TTN</i> co‐occurrent mutations in melanoma: A retrospective multi‐study analysis
2024-9-1
Building on and tailoring to: Adapting a cancer caregiver psychoeducational intervention for rural settings
2024-9-1
Issue Information
2024-9-1
<scp><i>PIK3CA</i></scp> mutational status in tissue and plasma as a prognostic biomarker in <scp>HR</scp>+/<scp>HER2−</scp> breast cancer
2024-9-1
The <scp>COVID</scp>‐19 pandemic and associated declines in cancer incidence by race/ethnicity and census‐tract level <scp>SES</scp>, rurality, and persistent poverty status
2024-9-1
The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
2024-9-1
The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification
2024-9-1
Serum matrix metalloproteinase‐7, Syndecan‐1, and <scp>CA</scp> 19‐9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma
2024-9-1
Phase <scp>I</scp>b/<scp>II</scp> study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (<scp>JK1201I</scp>) as second‐line monotherapy for patients with small‐cell lung cancer
2024-9-1
Evaluating implementation of a hospital‐based cancer registry to improve childhood cancer care in low‐ and middle‐income countries
2024-9-1
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
2024-9-1
Potential therapeutic effects of apigenin for colorectal adenocarcinoma: A systematic review and meta‐analysis
2024-9-1
Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study
2024-9-1
Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (<scp>COS</scp>‐Q)
2024-9-1
Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis
2024-9-1
A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China
2024-9-1
Preservation of <scp>cfRNA</scp> in cytological supernatants for <scp>cfDNA</scp> & <scp>cfRNA</scp> double detection in non‐small cell lung cancer patients
2024-9-1
Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
2024-9-1
Correction to: Initial ribociclib plus endocrine therapy for HR+/HER2− advanced breast cancer in pre‐ and postmenopausal Chinese women: Primary results from a phase 2 randomized study
2024-9-1
Radiomic prediction for durable response to high‐dose methotrexate‐based chemotherapy in primary central nervous system lymphoma
2024-9-1
Prognostic value of tumor‐infiltrating lymphocytes and <scp>PD</scp>‐<scp>L1</scp> expression in esophageal squamous cell carcinoma
2024-9-1
Correction to “Structure‐based pharmacophore modeling for precision inhibition of mutant <scp>ESR2</scp> in breast cancer: A systematic computational approach”
2024-9-1
Correction to “Comprehensive analysis of clinical prognosis and biological significance of <scp>CNIH4</scp> in cervical cancer”WangJ, WangS, WangJ, HuangJ, LuH, PanB, PanH, SongY, DengQ, JinX, ShiG. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer. Cancer Med.2023;12(24):22381–22394. doi: 10.1002/cam4.6734
2024-9-1
Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer
2024-9-1
Immune‐dysregulation harnessing in myeloid neoplasms
2024-9-1
Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study
2024-9-1
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
2024-9-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远